FDA takes steps to decrease barriers for overdose reversal agents with Dr. Marta Sokolowska - Q&A with FDA Podcast

Welcome to another episode of our podcast series, “Q&A with FDA”, from the FDA’s Division of Drug Information, where we answer some of the most frequently asked questions that we’ve received. In a previous episode, we discussed FDA’s Overdose Prevention Framework with Dr. Marta Sokolowska, Deputy Center Director for Substance Use and Behavioral Health in FDA’s Center for Drug Evaluation and Research. 

Read more (or listen to the podcast)